294 related articles for article (PubMed ID: 29131352)
21. Self-efficacy mediates the effects of topiramate and GRIK1 genotype on drinking.
Kranzler HR; Armeli S; Wetherill R; Feinn R; Tennen H; Gelernter J; Covault J; Pond T
Addict Biol; 2016 Mar; 21(2):450-9. PubMed ID: 25496338
[TBL] [Abstract][Full Text] [Related]
22. Posttreatment effects of topiramate treatment for heavy drinking.
Kranzler HR; Wetherill R; Feinn R; Pond T; Gelernter J; Covault J
Alcohol Clin Exp Res; 2014 Dec; 38(12):3017-23. PubMed ID: 25581656
[TBL] [Abstract][Full Text] [Related]
23. GABRA2, alcohol, and illicit drug use: An event-level model of genetic risk for polysubstance use.
Mallard TT; Ashenhurst JR; Harden KP; Fromme K
J Abnorm Psychol; 2018 Feb; 127(2):190-201. PubMed ID: 29528673
[TBL] [Abstract][Full Text] [Related]
24. Relationships between impulsivity and subjective response in an IV ethanol paradigm.
Leeman RF; Ralevski E; Limoncelli D; Pittman B; O'Malley SS; Petrakis IL
Psychopharmacology (Berl); 2014 Jul; 231(14):2867-76. PubMed ID: 24553574
[TBL] [Abstract][Full Text] [Related]
25. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
[TBL] [Abstract][Full Text] [Related]
26. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Kranzler HR; Covault J; Feinn R; Armeli S; Tennen H; Arias AJ; Gelernter J; Pond T; Oncken C; Kampman KM
Am J Psychiatry; 2014 Apr; 171(4):445-52. PubMed ID: 24525690
[TBL] [Abstract][Full Text] [Related]
27. Association of GABAA receptor α2 subunit gene (GABRA2) with alcohol dependence-related aggressive behavior.
Strac DS; Erjavec GN; Perkovic MN; Sviglin KN; Borovecki F; Pivac N
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():119-25. PubMed ID: 26116794
[TBL] [Abstract][Full Text] [Related]
28. A cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use.
Otto JM; Gizer IR; Deak JD; Fleming KA; Bartholow BD
Alcohol Clin Exp Res; 2017 May; 41(5):929-938. PubMed ID: 28273335
[TBL] [Abstract][Full Text] [Related]
29. Validation of the brief Biphasic Alcohol Effects Scale (B-BAES).
Rueger SY; King AC
Alcohol Clin Exp Res; 2013 Mar; 37(3):470-6. PubMed ID: 23078583
[TBL] [Abstract][Full Text] [Related]
30. GABRA2 Alcohol Dependence Risk Allele is Associated with Reduced Expression of Chromosome 4p12 GABAA Subunit Genes in Human Neural Cultures.
Lieberman R; Kranzler HR; Joshi P; Shin DG; Covault J
Alcohol Clin Exp Res; 2015 Sep; 39(9):1654-64. PubMed ID: 26250693
[TBL] [Abstract][Full Text] [Related]
31. Association of Anticipated and Laboratory-Derived Alcohol Stimulation, Sedation, and Reward.
Fridberg DJ; Rueger SY; Smith P; King AC
Alcohol Clin Exp Res; 2017 Jul; 41(7):1361-1369. PubMed ID: 28493556
[TBL] [Abstract][Full Text] [Related]
32. Induced pluripotent stem cell reprogramming-associated methylation at the GABRA2 promoter and chr4p12 GABA
Goetjen A; Watson M; Lieberman R; Clinton K; Kranzler HR; Covault J
Am J Med Genet B Neuropsychiatr Genet; 2020 Dec; 183(8):464-474. PubMed ID: 33029895
[TBL] [Abstract][Full Text] [Related]
33. Molecular Correlates of Topiramate and GRIK1 rs2832407 Genotype in Pluripotent Stem Cell-Derived Neural Cultures.
Lieberman R; Jensen KP; Clinton K; Levine ES; Kranzler HR; Covault J
Alcohol Clin Exp Res; 2020 Aug; 44(8):1561-1570. PubMed ID: 32574382
[TBL] [Abstract][Full Text] [Related]
34. Striatal activity correlates with stimulant-like effects of alcohol in healthy volunteers.
Weafer J; Ross TJ; O'Connor S; Stein EA; de Wit H; Childs E
Neuropsychopharmacology; 2018 Dec; 43(13):2532-2538. PubMed ID: 30093699
[TBL] [Abstract][Full Text] [Related]
35. GRIK1 genotype and daily expectations of alcohol's positive effects moderate the reduction of heavy drinking by topiramate.
Kranzler HR; Armeli S; Tennen H; Gelernter J; Covault J
Exp Clin Psychopharmacol; 2014 Dec; 22(6):494-501. PubMed ID: 25436841
[TBL] [Abstract][Full Text] [Related]
36. Subjective response to alcohol among alcohol-dependent individuals: effects of the μ-opioid receptor (OPRM1) gene and alcoholism severity.
Ray LA; Bujarski S; MacKillop J; Courtney KE; Monti PM; Miotto K
Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1(Suppl 1):E116-24. PubMed ID: 23240711
[TBL] [Abstract][Full Text] [Related]
37. The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption.
Sloan ME; Klepp TD; Gowin JL; Swan JE; Sun H; Stangl BL; Ramchandani VA
Neuropsychopharmacology; 2018 Jun; 43(7):1530-1538. PubMed ID: 29497164
[TBL] [Abstract][Full Text] [Related]
38. Bidirectional interactions between acute psychosocial stress and acute intravenous alcohol in healthy men.
Childs E; O'Connor S; de Wit H
Alcohol Clin Exp Res; 2011 Oct; 35(10):1794-803. PubMed ID: 21762177
[TBL] [Abstract][Full Text] [Related]
39. Subjective Effects of Alcohol Predict Alcohol Choice in Social Drinkers.
Li J; Murray CH; Weafer J; de Wit H
Alcohol Clin Exp Res; 2020 Dec; 44(12):2579-2587. PubMed ID: 33201577
[TBL] [Abstract][Full Text] [Related]
40. Topiramate's reduction of body mass index in heavy drinkers: lack of moderation by a GRIK1 polymorphism.
Kranzler HR; Feinn R; Gelernter J; Pond T; Covault J
Exp Clin Psychopharmacol; 2014 Oct; 22(5):419-23. PubMed ID: 24978347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
